Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
13F holders, Q1 2024
Institutional positions in Mesoblast Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −5 vs. Q4 2023
- Shares held
- 1.08M
- +359.5K (+49.6%) vs. Q4 2023Converted for a 1-for-2 split
- Total value
- $5.48M
- +$3.89M (+243.7%) vs. Q4 2023
- New holders
- 9
- 10 more added
- Sold out
- 14
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MESO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $53.3M |
| Q1 2026 | 69 | $50.5M |
| Q4 2025 | 75 | $75.7M |
| Q3 2025 | 68 | $58.9M |
| Q2 2025 | 72 | $36.8M |
| Q1 2025 | 68 | $49.2M |
| Q4 2024 | 61 | $59.9M |
| Q3 2024 | 43 | $12.4M |
| Q2 2024 | 39 | $10.1M |
| Q1 2024 | 26 | $5.48M |
| Q4 2023 | 31 | $1.59M |
| Q3 2023 | 35 | $1.63M |
| Q2 2023 | 43 | $7.00M |
| Q1 2023 | 44 | $7.97M |
| Q4 2022 | 42 | $7.89M |
| Q3 2022 | 37 | $10.3M |
| Q2 2022 | 33 | $7.06M |
| Q1 2022 | 37 | $13.1M |
| Q4 2021 | 42 | $16.2M |
| Q3 2021 | 41 | $21.2M |
| Q2 2021 | 50 | $28.9M |
| Q1 2021 | 52 | $21.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Mesoblast Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 143,671 | $719.8K | 0.03% | +62,961+78.0% | AddedConverted for a 1-for-2 split |
| Summit X, LLC | 139,752 | $700.2K | 0.18% | +124,247+801.3% | AddedConverted for a 1-for-2 split |
| Penbrook Management LLC | 125,175 | $627.1K | 0.39% | −12,500−9.1% | ReducedConverted for a 1-for-2 split |
| VGI Partners Ltd | 117,243 | $587.4K | 0.06% | +117,243 | New |
| Prosperity Wealth Management, Inc. | 77,350 | $387.5K | 0.18% | +77,350 | New |
| Morgan Stanley | 68,902 | $345.2K | 0.00% | −86,320−55.6% | ReducedConverted for a 1-for-2 split |
| Chase Investment Counsel Corp | 59,600 | $298.0K | 0.11% | +59,600 | New |
| Wells Fargo & Company | 59,214 | $296.7K | 0.00% | +3,133+5.6% | AddedConverted for a 1-for-2 split |
| HRT Financial LP | 57,815 | $289.0K | 0.00% | +57,815 | New |
| Susquehanna International Group, LLP | 57,506 | $288.1K | 0.00% | −55,558−49.1% | ReducedConverted for a 1-for-2 split |
| Lazari Capital Management, Inc. | 50,167 | $251.3K | 0.14% | +2,450+5.1% | AddedConverted for a 1-for-2 split |
| Fi3 FINANCIAL ADVISORS, LLC | 20,200 | $151.5K | 0.07% | +20,200 | New |
| Millennium Management LLC | 24,667 | $123.6K | 0.00% | +17,313+235.4% | AddedConverted for a 1-for-2 split |
| LPL Financial LLC | 20,787 | $104.1K | 0.00% | +14,349+222.9% | AddedConverted for a 1-for-2 split |
| Bank of America Corp | 11,688 | $58.6K | 0.00% | +4,040+52.8% | AddedConverted for a 1-for-2 split |
| BlackRock Inc. | 10,835 | $54.3K | 0.00% | +3,356+44.9% | AddedConverted for a 1-for-2 split |
| Chapin Davis, Inc. | 10,000 | $50.1K | 0.02% | +1,500+17.6% | AddedConverted for a 1-for-2 split |
| Tobias Financial Advisors, Inc. | 10,000 | $50.1K | 0.01% | +10,000 | New |
| Rhumbline Advisers | 9,076 | $45.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-2 split |
| Tower Research Capital LLC (TRC) | 3,410 | $17.1K | 0.00% | +3,410 | New |
| GAMMA Investing LLC | 3,318 | $16.6K | 0.00% | +2,973+861.7% | AddedConverted for a 1-for-2 split |
| Institutional & Family Asset Management, LLC | 1,484 | $7.43K | 0.00% | 00.0% | UnchangedConverted for a 1-for-2 split |
| Compagnie Lombard Odier SCmA | 1,000 | $5.01K | 0.00% | 00.0% | UnchangedConverted for a 1-for-2 split |
| Comerica Bank | 993 | $4.97K | 0.00% | +993 | New |
| Cutler Group LP | 500 | $2.00K | 0.00% | +500 | New |
| Advisor Group Holdings, Inc. | 32 | $160 | 0.00% | −26−44.8% | ReducedConverted for a 1-for-2 split |
| Lattice Capital Management, LLC | 0 | $0 | 0.00% | −15,050−100.0% | Sold outConverted for a 1-for-2 split |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −12,218−100.0% | Sold outConverted for a 1-for-2 split |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold outConverted for a 1-for-2 split |
| Diligent Investors, LLC | 0 | $0 | 0.00% | −5,500−100.0% | Sold outConverted for a 1-for-2 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −5,424−100.0% | Sold outConverted for a 1-for-2 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −5,004−100.0% | Sold outConverted for a 1-for-2 split |
| Aries Wealth Management | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-2 split |
| Blue Zone Wealth Advisors, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-2 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,669−100.0% | Sold outConverted for a 1-for-2 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,092−100.0% | Sold outConverted for a 1-for-2 split |
| UBS Group AG | 0 | $0 | 0.00% | −850−100.0% | Sold outConverted for a 1-for-2 split |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −582−100.0% | Sold outConverted for a 1-for-2 split |
| Arlington Trust Co LLC | 0 | $0 | 0.00% | −86−100.0% | Sold outConverted for a 1-for-2 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −96−100.0% | Sold outConverted for a 1-for-2 split |